Therefore, we demonstrated that colorectal cancer stem cells in the ALDH+/CD133+ cells expressed an activated form of STAT3, and this is the first report that demonstrates that these cancer stem cells are sensitive to GO-Y030 inhibition. This evidence concerns the gene STAT3 and colorectal cancer.